Genting Sing is the most active stock, followed by Sembcorp Ind (2.76%) and YZJ Shipbldg SGD (+2.69%). Wilmar Intl and DFIRG USD were at the foot.
Singapore led Southeast Asia in healthtech and life sciences funding in 2024, raising $92.4m across 14 rounds, Traxcn reported.